Warminster-based Arbutus Biopharma laid off over half of its workforce and is exiting its headquarters to conserve cash while continuing its pursuit of a hepatitis B cure, writes John George for the ...

TORONTO, ON / ACCESS Newswire / April 1, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce the signing of a non-binding Letter of ...

Keep updated, follow The Business Standard's Google news channel The report documents religious freedom conditions in 2024 and recommends policies to the White House, Congress and State Department to ...

Along with its Q4 2024 financials on Thursday, antiviral developer Arbutus Biopharma (NASDAQ:ABUS) announced plans to reduce its workforce by 57% as part of a broader restructuring program ...